Enzerna Biosciences Inc.
Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy.
Company Location
5151 McCrimmon Parkway, Suite 240
Morrisville
NC
27560
Phone
County
Region
Company Details
Company type
Year founded
2014
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
Gene Therapy for Nucleotide Expansion Disorders